Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-27
2006-06-27
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07067481
ABSTRACT:
This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
REFERENCES:
patent: 4220761 (1980-09-01), Takaya et al.
patent: 4341775 (1982-07-01), Takaya et al.
patent: 4366153 (1982-12-01), Takaya et al.
patent: 4487767 (1984-12-01), Takaya et al.
patent: 4921851 (1990-05-01), Kishimoto et al.
patent: 4943567 (1990-07-01), Nishizawa et al.
patent: 5693791 (1997-12-01), Truett et al.
patent: 6392012 (2002-05-01), Judice et al.
patent: 6437119 (2002-08-01), Truett
patent: 6444786 (2002-09-01), Judice et al.
patent: 6455669 (2002-09-01), Judice et al.
patent: 6518242 (2003-02-01), Chen et al.
patent: 6878686 (2005-04-01), Marquess et al.
patent: 2003/0130173 (2003-07-01), Fatheree et al.
patent: 2004/0033939 (2004-02-01), Marquess et al.
patent: 2005/0026818 (2005-02-01), Fatheree et al.
patent: 2 033 377 (1980-05-01), None
patent: 60-41682 (1985-03-01), None
patent: WO 99/42476 (1999-08-01), None
patent: WO 99/64049 (1999-12-01), None
patent: WO 00/39156 (2000-07-01), None
patent: WO 03/031449 (2003-04-01), None
patent: WO 03/099858 (2003-12-01), None
U.S. Appl. No. 09/457,926, filed Dec. 8, 1999, Christensen et al.
Boechkh et al., “Pharmacokinetics and Serum Bactericidal Activity of Vancomycin Alone and in Combination with Ceftazidime in Healthy Volunteers”, Antimicrobial Agents and Chemotherapy, vol. 32. No. 1, pp. 95-95 (1988).
Bryskier, “Cephems:Fifty Years of Continuous Research”, The Journal of Antibiotics, vol. 53, No. 10, pp. 1028-1037 (2000).
Bryskier, “Novelties in the field of parenteral cephem antibacterials since 1993”, Exp. Opin. Invest. Drugs, 6(3), pp. 305-320 (1997).
Hammes, “Biosynthesis of Peptidoglycan inGaffkya homari. The mode of action of Penicillin G and Mecillinam”, Eur. J. Biochem., 70, pp. 107-113 (1976).
Hammes, “Biosynthesis of peptidoglycan inGaffkya homari. The mode of action of penicillin G and mecillinam”, Chemical Abstracts, vol. 86, No. 5, Abstract No. 26406 (1977).
Kim et al., “Synthesis and Antibacterial Activity of Cephalosporins Having Hydroxamic Acid at C-7 Position” Biorganic & Med. Chem. Letters. vol. 6, No. 17, pp. 2077-2080 (1996).
Kim et al., “Patents on β-lactam antibacterials: Jan. 1999 to Mar. 2001”, Expert Opin. Ther. Patents, 11(8), pp. 1267-1276 (2001).
Lattrell et al., “Synthesis and Structure-Activity Relationships in the Cefpirome Series.” Journal of Antibiotics. vol. XLI, No. 10, pp. 1374-1394 (1988).
Nicolaou et al., “Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics”, Angew. Chem. Intl. Ed., 38, pp. 2096-2152 (1999).
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, pp. 509-513 (1997).
Pavlov et al., “Chemical Modification of Glycopeptide Antibiotics [VC1]”, Russian Journal of Bioorganic Chemistry, vol. 24, No. 9, pp. 570-587 (1998).
Rao et al., “Tight Binding of a Dimeric Derivative of Vancoymycin with Dimeric L-Lys-D-Ala-D-Ala”, J. Am. Chem. Soc. vol. 119, pp. 10286-10290 (1997).
Renoud-Grappin et al., “Imidazo[1,5-b]pyridazine-d4T conjugates:synthesis and anti-human immunodeficiency virus evaluation”, Antiviral Chemistry & Chemotherapy, vol. 9, pp. 205-223 (1998).
Staroske et al., “Synthesis of Covalent Head-to-Tail Dimers of Vancomycin”, Tetrahedron Letters 39, pp. 4917-4920 (1998).
Sundram et al., “General and Efficient Method for the Solution- and Solid-Phase Synthesis of Vancomycin Carboxamide Derivatives”, J. Org. Chem., vol. 60, pp. 1102-1103 (1995).
Sundram et al., “Novel Vancomycin Dimers with Activity against Vancomycin-Resistant Enterococci”, J. Am. Chem. Soc. , vol. 118, pp. 13107-13108 (1996).
Aggen James B.
Chinn Jason P.
Fatheree Paul R.
Linsell Martin S.
Long Daniel D.
Campell Bruce R.
Hagenah Jeffrey A.
Heard Thomas S.
Theravance Inc.
LandOfFree
Cross-linked glycopeptide-cephalosporin antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-linked glycopeptide-cephalosporin antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-linked glycopeptide-cephalosporin antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3696074